BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34407819)

  • 1. Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory.
    Jin Y; Yu S; Liu JJ; Yun EJ; Lee JW; Jin YS; Kim KH
    Microb Cell Fact; 2021 Aug; 20(1):160. PubMed ID: 34407819
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Durmusoglu D; Al'Abri IS; Collins SP; Cheng J; Eroglu A; Beisel CL; Crook N
    ACS Synth Biol; 2021 May; 10(5):1039-1052. PubMed ID: 33843197
    [No Abstract]   [Full Text] [Related]  

  • 3. New biomarkers underlying acetic acid tolerance in the probiotic yeast Saccharomyces cerevisiae var. boulardii.
    Samakkarn W; Vandecruys P; Moreno MRF; Thevelein J; Ratanakhanokchai K; Soontorngun N
    Appl Microbiol Biotechnol; 2024 Jan; 108(1):153. PubMed ID: 38240846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of BpGH16A of Bacteroides plebeius, a key enzyme initiating the depolymerization of agarose in the human gut.
    Park NJ; Yu S; Kim DH; Yun EJ; Kim KH
    Appl Microbiol Biotechnol; 2021 Jan; 105(2):617-625. PubMed ID: 33404831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast
    Offei B; Vandecruys P; De Graeve S; Foulquié-Moreno MR; Thevelein JM
    Genome Res; 2019 Sep; 29(9):1478-1494. PubMed ID: 31467028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeasts as probiotics: Mechanisms, outcomes, and future potential.
    Sen S; Mansell TJ
    Fungal Genet Biol; 2020 Apr; 137():103333. PubMed ID: 31923554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Engineering of Probiotic Saccharomyces boulardii.
    Liu JJ; Kong II; Zhang GC; Jayakody LN; Kim H; Xia PF; Kwak S; Sung BH; Sohn JH; Walukiewicz HE; Rao CV; Jin YS
    Appl Environ Microbiol; 2016 Apr; 82(8):2280-2287. PubMed ID: 26850302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Mutation in
    Liu JJ; Zhang GC; Kong II; Yun EJ; Zheng JQ; Kweon DH; Jin YS
    Appl Environ Microbiol; 2018 May; 84(10):. PubMed ID: 29523547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcoholic and non-alcoholic rosé wines made with Saccharomyces cerevisiae var. boulardii probiotic yeast.
    Mulero-Cerezo J; Tuñón-Molina A; Cano-Vicent A; Pérez-Colomer L; Martí M; Serrano-Aroca Á
    Arch Microbiol; 2023 Apr; 205(5):201. PubMed ID: 37081186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiome Engineering Using Probiotic Yeast:
    Kim J; Atkinson C; Miller MJ; Kim KH; Jin YS
    Microbiol Spectr; 2023 Aug; 11(4):e0078023. PubMed ID: 37436157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Saccharomyces cerevisiae var. boulardii in co-fermentations with S. cerevisiae for the production of craft beers with potential healthy value-added.
    Capece A; Romaniello R; Pietrafesa A; Siesto G; Pietrafesa R; Zambuto M; Romano P
    Int J Food Microbiol; 2018 Nov; 284():22-30. PubMed ID: 29990636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain engineering and metabolic flux analysis of a probiotic yeast Saccharomyces boulardii for metabolizing L-fucose, a mammalian mucin component.
    Kim J; Cheong YE; Yu S; Jin YS; Kim KH
    Microb Cell Fact; 2022 Oct; 21(1):204. PubMed ID: 36207743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth, survival, and metabolic activities of probiotics Lactobacillus rhamnosus GG and Saccharomyces cerevisiae var. boulardii CNCM-I745 in fermented coffee brews.
    Chan MZA; Toh M; Liu SQ
    Int J Food Microbiol; 2021 Jul; 350():109229. PubMed ID: 34023682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissection and enhancement of prebiotic properties of yeast cell wall oligosaccharides through metabolic engineering.
    Kwak S; Robinson SJ; Lee JW; Lim H; Wallace CL; Jin YS
    Biomaterials; 2022 Mar; 282():121379. PubMed ID: 35078005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-promoting properties of
    Ansari F; Alian Samakkhah S; Bahadori A; Jafari SM; Ziaee M; Khodayari MT; Pourjafar H
    Crit Rev Food Sci Nutr; 2023; 63(4):457-485. PubMed ID: 34254862
    [No Abstract]   [Full Text] [Related]  

  • 16. Unique Probiotic Properties and Bioactive Metabolites of Saccharomyces boulardii.
    Fu J; Liu J; Wen X; Zhang G; Cai J; Qiao Z; An Z; Zheng J; Li L
    Probiotics Antimicrob Proteins; 2023 Aug; 15(4):967-982. PubMed ID: 35608794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant properties and global metabolite screening of the probiotic yeast Saccharomyces cerevisiae var. boulardii.
    Datta S; Timson DJ; Annapure US
    J Sci Food Agric; 2017 Jul; 97(9):3039-3049. PubMed ID: 27868205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics analysis of potential functional metabolites in synbiotic ice cream made with probiotic Saccharomyces cerevisiae var. boulardii CNCM I-745 and prebiotic inulin.
    Zhou Z; Sarwar A; Xue R; Hu G; Wu J; Aziz T; Alasmari AF; Yang Z; Yang Z
    Food Chem; 2024 Oct; 454():139839. PubMed ID: 38810444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fructooligosaccharides and Saccharomyces boulardii on the compositional structure and metabolism of gut microbiota in students.
    Fu H; Chen Z; Teng W; Du Z; Zhang Y; Ye X; Yu Z; Zhang Y; Pi X
    Microbiol Res; 2024 Aug; 285():127741. PubMed ID: 38761487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing probiotic impact: engineering
    de Carvalho BT; Subotić A; Vandecruys P; Deleu S; Vermeire S; Thevelein JM
    Appl Environ Microbiol; 2024 Jun; 90(6):e0032524. PubMed ID: 38752748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.